Market Overview

Morning Market Movers

Related IPCI
Top Performing Industries For October 23, 2014
Intellipharmaceutics Reports Positive Results From A Series of Phase I Clinical Trials Of Regabatin XR
Related SPEX
Morning Market Losers
Spherix Announces First Trial of Nortel Patents Since Bankruptcy Scheduled vs Verizon for Q1 2015

IntelliPharmaCeutics International (NASDAQ: IPCI) rose 76.72% to $3.34 following Monday announcement of commercial launch of 15, 30mg Generic Focalin XR.

Spherix (NASDAQ: SPEX) jumped 70.07% to $12.50 after the company announced the settlement agreement and continued monetization of patent portfolio.

Evoke Pharma (NASDAQ: EVOK) shares jumped 41.10% to $11.50 after Aegis Capital initiated coverage on the stock with a Buy rating and a $60.00 price target.

Horizon Pharma (NASDAQ: HZNP) moved up 32.88% to $5.9399 after the company announced an agreement to acquire U.S. rights to VIMOVO. The company also announced pricing of $150 million of 5.00% convertible senior notes.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (HZNP + EVOK)

Around the Web, We're Loving...

Get Benzinga's Newsletters